SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trillium Therapeutics
TRIL 20.78+0.2%Nov 3 2:45 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bladerunner17 who wrote (215)10/7/2018 3:19:09 PM
From: Biomaven  Read Replies (1) of 294
 
Reasonable piece in TRIL - wouldn't call it particularly negative. The data on CTCL make it an approvable drug at the end of the day, so on that basis alone I think it is cheap and I actually bought more on Friday ahead of ASH data. They still need to figure out combos better, and they really should partner sooner rather than later.

Market worried about another offering here I suspect.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News